Literature DB >> 7010003

10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).

V Fuster, J H Chesebro.   

Abstract

In this three-part series, the first part described the role of platelets in thrombogenesis, this second part considers the pharmacologic effects of platelet-inhibitor drugs, and the third part will discuss their clinical application. This second article comprises (1) the physiologic contribution of the vessel wall to the prevention of thrombosis, particularly the role of prostacyclin, (2) the mechanisms of action of platelet-inhibitor drugs in the prevention of thrombosis, (3) the ideal dose and ideal therapeutic combinations of conventional platelet-inhibitor drugs, (4) other agents and new agents that inhibit platelet function, and (5) drug side effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7010003

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man.

Authors:  A Eldor; E Zylber-Katz; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.

Authors:  K S Hilliker; R A Roth
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

3.  Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.

Authors:  I B Johnstone
Journal:  Can J Comp Med       Date:  1983-04

4.  The role of Odontella aurita, a marine diatom rich in EPA, as a dietary supplement in dyslipidemia, platelet function and oxidative stress in high-fat fed rats.

Authors:  Adil Haimeur; Lionel Ulmann; Virginie Mimouni; Frédérique Guéno; Fabienne Pineau-Vincent; Nadia Meskini; Gérard Tremblin
Journal:  Lipids Health Dis       Date:  2012-10-31       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.